Vortioxetine as a potential alternative for patients with escitalopram‐induced jitteriness/anxiety syndrome: A report of three cases
Kaoru Arai, Mari Nonaka, Shoko Shimada, Masayuki Nakamura · 2023
Read Vortioxetine as a potential alternative for patients with escitalopram‐induced jitteriness/anxiety syndrome: A report of three cases by Kaoru Arai, Mari Nonaka, Shoko Shimada, Masayuki Nakamura (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11114283.txt.
Description
Kaoru Arai, Mari Nonaka, Shoko Shimada, and Masayuki Nakamura present a 2023 report of three patients whose antidepressant sparked a jittery anxiety state. The syndrome, a known early side effect of such drugs, leaves patients restless and wound up. All three cases arose on escitalopram, a widely used drug for depression. The authors test a switch to a second drug, vortioxetine, as a way out.
One man's mood shot up three months in, with racing talk and acts that broke his routine. The switch settled him. A woman's mood spiked in six days; after the first drug stopped and three others failed, she sank and had thoughts of self-harm. The second drug steadied her and she went back to work. A third case rounds out the set. Small case sets can still flag a workable switch.
Catalog record
| CREATOR | Kaoru Arai, Mari Nonaka, Shoko Shimada, Masayuki Nakamura |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |